Targeting the Pathway or the Cytokine? Network Meta-Analysis of JAK1 vs. IL-17 Inhibitors in Hidradenitis Suppurativa

2026 Preprint Open access

Read full text
Authors: Ayhan Ozan Ozdemir
DOI: 10.17605/osf.io/d94ur
Cited by: 0

Abstract

Protocol for a systematic review and Bayesian Network Meta-Analysis (NMA) comparing the efficacy of oral JAK1 inhibitors (povorcitinib, upadacitinib) versus IL-17 inhibitors (bimekizumab, secukinumab) and adalimumab in moderate-to-severe Hidradenitis Suppurativa.

Fields of Study & Subjects

Hidradenitis Suppurativa and Treatments Autoimmune and Inflammatory Disorders Osteomyelitis and Bone Disorders Research

Publication details

Publication date
1 January 2026
Document type
Preprint